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ABSTRACT
In vitro display methods are superior tools for
obtaining monoclonal antibodies. Although totally
in vitro display methods, such as ribosome display
and mRNA display, have the advantages of larger
library sizes and quicker selection procedures
compared with phage display, their applications
have been limited to single-chain Fvs due to the
requirement for linking of the mRNA and the
nascent protein on the ribosome. Here we
describe a different type of totally in vitro method,
DNA display, that is applicable to heterodimeric Fab
fragments: in vitro compartmentalization in water-
in-oil emulsions allows the linking of an oligomeric
protein and its encoding DNA with multiple ORFs.
Since previously used emulsions impaired the syn-
thesis of functional Fab fragments, we modified
conditions for preparing emulsions, and identified
conditions under which it was possible to enrich
Fab fragments 10
6-fold per three rounds of affinity
selection. Furthermore, we confirmed that genes
encoding stable Fab fragments could be selected
from a Fab fragment library with a randomized
hydrophobic core in the constant region by
applying heat treatment as a selection pressure.
Since this method has all advantages of both
phage display and totally in vitro display, it
represents a new option for many applications
using display methods.
INTRODUCTION
Due to their highly diverse and speciﬁc antigen-binding
ability, monoclonal antibodies are widely used in many
areas, from basic research to industrial and therapeutic
applications. In vitro selection of recombinant antibodies
using antibody-display methods is an eﬀective tool
for obtaining these monoclonal antibodies (1). In particu-
lar, the totally in vitro display methods such as
ribosome display (2) and mRNA display (3,4) have the
advantage of permitting speedy selection from large
libraries. However, these methods link the genotype and
phenotype on the ribosome, so that they are only applica-
ble to single-chain Fvs (scFvs) (5,6), and cannot be applied
to oligomeric proteins such as whole IgGs or even
heterodimeric Fab fragments. Selection of oligomeric
proteins, Fab fragments in particular, has only been
carried out with partially in vitro display methods,
such as phage display (7) and yeast-surface display (8),
which have limitations arising from the need to use
Escherichia coli or yeast during the process. Compared
to the commonly used scFv, Fab fragments have no
artiﬁcial sequence and contain the constant region,
being more antibody-like. Also, because the constant
region stabilizes the whole Fab fragment (9,10), the
Fab fragment is more stable than the scFv in most
cases (10,11). Therefore, a novel display method
for totally in vitro selection of Fab fragments would be
very useful.
In this study we adopted a DNA display method,
STABLE (12–14), to establish a procedure that
combines the merits of both of these display methods,
i.e. one that would be totally in vitro and also applicable
to oligomeric proteins. STABLE relies on in vitro
compartmentalization in water-in-oil emulsions (15) and
the streptavidin-biotin linkage. Since the DNA (genotype)
and transcribed/translated protein (phenotype) are
compartmentalized in a single micelle, a DNA with
multiple ORFs can be linked to the corresponding and
properly formed oligomeric protein. We ﬁrst investigated
the conditions of this DNA display method to optimize
it for the enrichment of Fab fragments by aﬃnity selec-
tion, and then successfully carried out a totally in vitro
selection from a Fab fragment library with a randomized
hydrophobic core in the constant region.
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DNA construction
The oligonucleotide sequences used are listed on Table 1.
The Heavy chain (H-chain) and Light chain (L-chain)
genes of an anti-ﬂuorescein Fab fragment were constructed
by two steps of PCR using KOD-plus DNA polymerase
(Toyobo).First, the variableandconstant region wereeach
constructed. The variable region was extracted by PCR
from scFv c12 with mutations H-D101N and L-H94Y (5)
using primers PFLVH-F and VH-R for the VH domain
(variable region of H-chain) and primers PFLVL-F and
VL-R for the VL domain (variable region of L-chain).
The constant region was assembled by overlap-extension
PCR using primers VHR-F, CHmyc-R and oligonu-
cleotides synCH1–3 for the CH1 domain (constant region
1 of H-chain) and primers VLR-F, CLFLAG-R and
oligonucleotides synCL1–3 for the CL domain (constant
region of L-chain). Second, the variable region and
constant region were assembled by overlap-extension
PCR using primers Universal and mycT7-R or primers
Universal and FLAGT7-R to make the H- and L-chain
genes, respectively. The ﬁnal PCR products were cloned
into pCR2.1-TOPO vector (Invitrogen), making an
H-chain gene containing a T7 promoter, a Shine-
Dalgarno (SD) sequence, and an ORF for the VH
domain, CH1 domain and a c-myc tag; and an L-chain
gene containing a T7 promoter, an SD sequence, and an
ORF for the VL domain, CL domain and a FLAG tag.
Similarly, the H- and L-chain genes of an anti-p53 Fab
fragment were constructed by two steps of PCR. First, the
variable region and constant region were extracted by
PCR. From scFv421 (16), primers P421VH-F and
421VHCHF-R or primers P421VL-F and 421VLCLF-R
were used to extract the VH and VL domains, respectively,
and from the constructed anti-ﬂuorescein Fab fragment
gene, primers CH-F and myc-R or primers CL-F and
FLAG-R were used to extract the CH1 domain and CL
domain, respectively. Second, the variable region and
constant region were assembled by overlap-extension
PCR, using the same procedure as for the anti-ﬂuorescein.
The ﬁnal PCR products were also cloned into pCR2.1-
TOPO vector.
The ﬁnal streptavidin-fused Fab fragment gene
construct was made by overlap-extension PCR using
KOD-plus DNA polymerase. The H- and L-chain genes
described above and a low GC content streptavidin gene
(13) were assembled by overlap-extension PCR using
primers Universal and FLAGT7-R. The PCR products
were cloned into pCR-XL-TOPO vector (Invitrogen) to
aﬀord the full construct containing a T7 promoter, an
SD sequence, the ﬁrst ORF for the VH domain, CH1
domain, c-myc tag, helical linker (14) and streptavidin,
an SD sequence, and the second ORF for the VL
domain, CL domain and a FLAG tag. The genes were
named anti-ﬂuoFab-STA for anti-ﬂuorescein and anti-
p53Fab-STA for anti-p53. From these genes, PCR was
carried out with primers Univ-F and T7-R to make non-
biotinylated template DNA and primers PCBUniv-F and
PCBT7-R to make photo-cleavable biotinylated template
DNA (17). These PCR products were puriﬁed using the
QIAquick PCR puriﬁcation kit (Qiagen).
Library construction
The DNA library of Fab fragments with a randomized
hydrophobic core in the constant region was constructed
by two steps of PCR (the positions of the randomized
seven residues are H-chain Val124, Leu141, Ser179,
Val181 and L-chain Phe118, Val133, Leu135). First, four
diﬀerent DNA fragments, H-L124, H-L141S179V181,
L-F118 and L-V133L135 were constructed from an
anti-ﬂuoFab-STA gene by PCR with KOD-plus DNA
polymerase using two primers, Universal and HL124-R,
HL141-F and HS179V181-R, x-F and LF118-R, and
LV133L135-F and FLAGT7-R, respectively. These four
fragments were mixed in equimolar amounts and
assembled by overlap-extension PCR with primers
PCBUniv-F and PCBT7-R to make biotinylated
template DNA. The PCR products were resolved by
agarose gel electrophoresis and the 2030bp band, which
resembles full-length streptavidin-fused Fab fragment
gene, was extracted and puriﬁed using the QIAquick gel
extraction kit (Qiagen).
Pull-down assay
Streptavidin-fused Fab fragments were expressed by
transcribing and translating 1pmol of non-biotinylated
template DNA with an E. coli reconstituted in vitro
transcription/translation system, PURE system S–S
(PostGenome Institute), for 2h at 37 C. Further,
100pmol of biotinylated antigen [either ﬂuorescein
(Sigma) or p53 C-terminal peptide (SKKGQSYSRH)] or
biotin was added to 100ml of 10% Neutravidin-
immobilized beads (Pierce) dispersed in PBS, gently
mixed at room temperature and ﬁnally washed with
100ml of PBST [PBS with 0.1% Tween 20 (Sigma)] three
times to prepare antigen-immobilized beads or mock
beads, respectively. To these antigen-immobilized beads
or mock beads was added 100ml of the expressed Fab
fragments diluted to 10% with PBST. After having been
gently mixed for 1h at 4 C for binding, the beads were
washed with 100ml of PBST three times and heated at
95 C for 10min to elute the bound Fab fragments. The
initial and the beads fractions were analyzed by 12.5%
SDS–PAGE with detection by western blotting using an
ECL western blotting kit (Amersham Biosciences) with
anti-FLAG M2 (Sigma) or anti-c-Myc 9E10 (Santa
Cruz) and anti-mouse HRP conjugate (Bio-Rad).
In vitro transcription and translation in emulsions
Emulsions were prepared by stirring 50ml of PURE system
S–S with 0–0.2% BSA (New England Biolabs) and 50pM
biotinylated template DNA into 950ml of mineral oil–
surfactant mixture [mineral oil (Nacalai Tesque) contain-
ing 0.45% Span 85 (Nacalai Tesque) and 0.05% Tween 20
or Tween 80 (Sigma)] at 2300r.p.m. for 0.5–3.0min at 4 C.
The emulsions were incubated at 37 C for 2h for transcrip-
tion and translation, then kept for more than 2h at 4 Ct o
let the large micelles subside. An 800-ml aliquot of the top
layer was collected, mixed with 220ml of Quenching Buﬀer
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(Nacalai Tesque) and 0.2% BSA], and centrifuged at
15000r.p.m. for 10min at 20 C to break the emulsion.
Approximately 90% of the aqueous layer from the
bottom was recovered and puriﬁed by brieﬂy mixing it
with 1ml of mineral oil, and centrifuging the mixture at
15000r.p.m. for 2min at 4 C. When necessary, heat treat-
ment for 10min was carried out before centrifugation.
From the puriﬁed aqueous layer, a 180ml aliquot was
recovered, mixed with 20ml of sonicated salmon sperm
DNA (Stratagene), and used for aﬃnity selection.
Aﬃnity selection
Fluorescein-immobilized beads were made by adding 1mg
of NHS-Fluorescein labeling reagent (Pierce) to 12mlo f
50% Dynabeads M-270 Amine (Dynal) dispersed in DMF
(Pierce), gently mixing it for 1h at room temperature and
washing it with 200ml of PBS twice. Blocking was done by
gently mixing 100ml of 0.03% ﬂuorescein-immobilized
beads in Block Buﬀer (DIG wash and block buﬀer
set, Roche) for 1h at room temperature. Then 100mlo f
solution containing DNA-displayed Fab fragments
described above was added to the beads and mixing was
done gently for 1h at 4 C for binding. The beads were
washed with 100ml of PBST twice, mixed with 100mlo f
PBS, and exposed to UV radiation at >300nm to elute the
selected DNA (17). For further rounds of selection, the
eluted DNA was ampliﬁed by means of KOD-plus
DNA polymerase with primers PCBUniv-F and PCBT7-
R, and puriﬁed with the QIAquick PCR puriﬁcation kit.
Table 1. Oligonucleotide sequences
Name Sequence (50 to 30)
421VHCHF-R GATGGGCCCTTGGTGGAGGCTGAGGAGACGGTGACCGTGGTC
421VLCLF-R GAAGACAGATGGTGCAGCCACAGTGCGTTTAATTTCCAGCTTGGTGCCAGC
CH-F GCCTCCACCAAGGGCCCATC
CHmyc-R AGATCCTCTTCAGAGATGAGTTTCTGCTCACAAG
CL-F ACTGTGGCTGCACCATCTGTCTTC
CLFLAG-R CTTGTCGTCATCGTCCTTGTAGTCACAC
FLAG-R CTTGTCGTCATCGTCCTTGTAGTC
FLAGT7-R GCTAGTTATTGCTCAGCGGTCGACTACTTGTCGTCATCGTCCTTGTAGTC
FluoH-F CAGGATCGAGTGGGTCAAAC
FluoH-R GGTGCTGGAGCTTTTGTCTG
HL124-R GCCGCTGTGCCCCCAGAGGTGCTCTTGGAGGAGGGTGCMANGGGGAAGACCGAT
HL141-F AGCACCTCTGGGGGCACAGCGGCCCTGGGCTGCNTKGTCAAGGACTACTTC
HS179V181-R GATGTAGGTCTGGGTGCCCAAGCTGCTGGAGGGCACGGTCACMANGCTMANGAGGGAGTAGAG
LF118-R TTCCAGATTTCAACTGCTCATCAGATGGCGGMANGATGAAGACAGA
LV133L135-F TCTGATGAGCAGTTGAAATCTGGAACTGCCTCTGTTNTKTGCNTKCTGAATAACTTCTATCCC
myc-R GAGATCCTCTTCAGAGATGAGTTTCTGCTC
mycT7-R GCTAGTTATTGCTCAGCGGTCGACTACAGATCCTCTTCAGAGATGAGTTTCTGCTC
P421VH-F AAGGAGATATACCAATGCAGGTGCAGCTGCAGCAGT
P421VL-F AAGGAGATATACCAATGGATGTTTTGATGACCCAAACTC
p53H-F GGCAGAGCTTGTAAGGTCAG
p53H-R CAATCCATCCAATCCACTCC
PCBUniv-F GAAATTAATACGACTCACTATAGG
PCBT7-R GCTAGTTATTGCTCAGCGG
PFLVH-F AAGGAGATATACCAATGGAGGTTCAGCTGCAGCAGT
PFLVL-F AAGGAGATATACCAATGGACATTGTGATGACCCAGTCTC
STAsd-R GTGGCATCTCCTTCACTGCTGAACAGCGTCCAGC
synCH1 GACTACCCTTACTGTCTCTTCCGCCTCCACCAAGGGCCCATCGGTCTTCCCCCTGGCACCCTCCTCCAAG
AGCACCTCTGGGGGCACAGCGGCCCTGGGCTGCCTGGTCAAGGACTACTTCCCCGAACCGGTGAC
synCH2 TACTTCCCCGAACCGGTGACGGTGTCGTGGAACTCAGGCGCCCTGACCAGCGGCGTGCACACCTTCCC
GGCTGTCCTACAGTCCTCAGGACTCTACTCCCTCAGCAGCGTGGTGACCGTGCCCTCCAGCAG
synCH3 GACCGTGCCCTCCAGCAGCTTGGGCACCCAGACCTACATCTGCAACGTGAATCACAAGCCCAGCAACAC
CAAGGTGGACAAGAAAGTTGAGCCCAAATCTTGTGAGCAGAAACTCATCTCTGAAGAGGATCTG
synCL1 GGACTAAGTTGGAACTCAAACGCACTGTGGCTGCACCATCTGTCTTCATCTTCCCGCCATCTGATGAG
CAGTTGAAATCTGGAACTGCCTCTGTTGTGTGCCTGCTGAATAACTTCTATCCCAGAGAGGCCAAAGTG
synCL2 CTATCCCAGAGAGGCCAAAGTGCAGTGGAAGGTGGATAACGCCCTCCAATCGGGTAACTCCCAGGAGA
GTGTCACAGAGCAGGACAGCAAGGACAGCACCTACAGCCTCAGCAGCACCCTGACGCTGAGCAAAG
synCL3 CACCCTGACGCTGAGCAAAGCAGACTACGAGAAACACAAAGTCTACGCCTGCGAAGTCACCCATCAGGG
CCTGAGCTCGCCCGTCACAAAGAGCTTCAACAGGGGAGAGTGTGACTACAAGGACGATGACGACAAG
T7-R GCTAGTTATTGCTCAGCGG
Univ-F GAAATTAATACGACTCACTATAGG
Universal GAAATTAATACGACTCACTATAGGGAGACCACAACGGTTTCCCTCTAGAAATAATTTTGTTTAACTTTAA
GAAGGAGATATACCA
VH-R GGAAGAGACAGTAAGGGTAGTC
VHR-F GACTACCCTTACTGTCTCTTCC
VL-R GCGTTTGAGTTCCAACTTAGTCC
VLR-F GGACTAAGTTGGAACTCAAACGC
x-F CTTGGGCACCCAGACCTACATCTGCAACGTGAATCACA
N=A, T, G or C; K=T or G; M=A or C.
PCBUniv-F and PCBT7-R are labeled with photo-cleavable biotin at the 50-end.
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gel electrophoresis and the 2030bp band was extracted
and puriﬁed with the QIAquick gel extraction kit.
Finally, the selected DNA was cloned using a TOPO XL
PCR cloning kit (Invitrogen) and sequenced with an ABI
3100 genetic analyzer (Applied Biosystems).
Quantitative real-time PCR
The DNA amount of each gene after each round was
quantiﬁed by real-time PCR using SYBR premix Ex Taq
DNA polymerase (Takara) and Lightcycler (Roche).
Primers FluoH-F and FluoH-R were used for anti-
ﬂuoFab-STA genes and primers p53H-F and p53H-R
were used for anti-p53Fab-STA genes.
ELISA, heat-denaturation ELISA and competitive ELISA
Selected clones were ampliﬁed by PCR with KOD-plus
DNA polymerase using primers Univ-F and T7-R, and
puriﬁed with the QIAquick PCR puriﬁcation kit. Fab
fragments were expressed by transcribing and translating
0.5pmol of the PCR products with the PURE system S–S
for 2h at 37 C. Meanwhile, a ﬂuorescein-immobilized
plate was prepared by adding 150pmol of biotinylated
ﬂuorescein and 100ml of Block Buﬀer to a Streptavidin
C8 Transparent plate (Nunc) and shaking it for 1h at
room temperature. The plate was then washed with
200ml of TBST (TBS with 0.1% Tween 20) 10 times and
blocked with 200ml of Block Buﬀer by shaking it for 1h
at room temperature. Separately, the expressed Fab
fragments were diluted into 100ml of Block Buﬀer con-
taining 0–20nM ﬂuorescein as a competitor. If heat
denaturation was necessary, this solution was then
heated at one of 8 equally spaced points between 38.7
and 71.2 C for 10min. The sample was then centrifuged
at 15000r.p.m. for 10min at 4 C and 90ml of the top layer
was recovered. When the competitor was added, the
sample was pre-incubated at 4 C for 1h. Then, the
samples were added to the ﬂuorescein-immobilized plate
and shaken for 20min. After a washing step, 100mlo f
TBST with 0.1% anti-FLAG M2 peroxidase conjugate
(Sigma) was added and shaking was continued for 1h.
The plate was washed for the last time and 100mlo f
TMB (Nacalai Tesque) was added. The plate was shaken
for  5min and then 100mlo f1 NH 2SO4 was added
to stop the reaction. The absorbance at 450nm was
measured (reference wavelength: 655nm). The Tm and
Kd values of the selected clones were estimated from the
sigmoid curve and the Scatchard plot, respectively.
RESULTS AND DISCUSSION
Strategy for in vitro selection of Fab fragments by
DNA display
The scheme for in vitro selection of Fab fragments using
DNA display is shown in Figure 1. First we constructed a
DNA encoding two ORFs, a streptavidin-fused H-chain
and an L-chain (for details, see ‘Materials and Methods’
section). The streptavidin-fused H-chain, which is the
Figure 1. Scheme of in vitro selection of Fab fragments using DNA display. Step 1: The template DNA has two ORFs (a streptavidin-fused H-chain
gene and an L-chain gene), one T7 promoter (T7) and two ribosomal binding sites (SD). The DNA library is biotinylated through a photo-cleavable
linker and compartmentalized in water-in-oil emulsions containing an in vitro transcription/translation system. Step 2: In each micelle, a streptavidin-
fused H-chain and an L-chain are expressed, forming a Fab fragment and linked to the corresponding DNA via streptavidin-biotin linkage. Step 3:
DNA-displayed Fab fragments are recovered from the emulsion and subjected to in vitro antigen selection. Step 4: Selected DNA-displayed Fab
fragments are exposed to UV irradiation at >300nm to cleave the DNA for elution. Step 5: Selected DNA is ampliﬁed by PCR with biotinylated
primers to make templates for the next round of selection. Step 6: After a suitable number of rounds of selection, the selected DNA is cloned and
sequenced to identify the selected Fab fragments.
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lower expression eﬃciency. Although Figure 1 depicts
only one biotin attached to the end of the DNA, the
actual construct had biotin on both ends, increasing the
avidity; since streptavidin forms a tetramer, possibly as
many as eight copies of Fab fragments were displayed
per DNA. The DNA library is in vitro transcribed/
translated in emulsions to form DNA-displayed Fab
fragments. These DNA-displayed Fab fragments are
selected by the target antigen and then the linker
between the biotin and DNA (17) is cleaved by exposure
to UV radiation at >300nm, allowing elution of the DNA
of the selected Fab fragments. The selected DNA is either
ampliﬁed by PCR with biotinylated primers for further
selection or sequenced to identify the selected Fab
fragments.
Improvement of DNA display for Fab fragments
In this study, we used an in vitro transcription/translation
system optimized for synthesis of proteins containing
disulﬁde bonds (18). First, we conﬁrmed the synthesis
and function of streptavidin-fused model Fab fragments
(anti-ﬂuorescein and anti-p53 antibodies) by western
blotting (Figure 2). Bands of both streptavidin-fused
H-chain (43kDa) and L-chain (24kDa) were detected at
positions corresponding to the appropriate molecular
weight in the presence of b-mercaptoethanol, while
a band near 90kDa was detected in the absence of
b-mercaptoethanol, indicating that Fab fragments with
disulﬁde bonds are properly formed. These Fab fragments
also bound to their antigens and retained antigen-binding
activity (Figure 2). DNA–protein conjugate formation for
these Fab fragments proceeded with an eﬃciency of over
95% (data not shown).
These model antibodies were used in a model aﬃnity
selection experiment, in which anti-ﬂuorescein was used as
a positive control and anti-p53 as a negative control.
When these DNA-displayed Fab fragments were
generated separately under emulsiﬁed or non-emulsiﬁed
conditions, mixed together, and subjected to a single
round of aﬃnity selection with ﬂuorescein-immobilized
beads, DNA-displayed Fab fragments generated inside
the emulsions showed greatly decreased DNA enrichment
eﬃciency ( 10%) and could only be enriched a few-fold
(data not shown). The emulsion preparation procedure
was presumed to have impaired the in vitro transcrip-
tion/translation system and/or destabilized the synthesized
Fab fragments as a result of the presence of the surfactants
and/or the stirring processes (the procedures used to
prepare the emulsions are described in ‘Materials and
Methods’ section). Therefore, we examined the conditions
of the method in detail in order to obtain a practical
enrichment eﬃciency for Fab fragment DNA.
Thefollowingthreechangesresultedinmarkedimprove-
ment of the DNA enrichment eﬃciency compared with
the original conditions (Figure 3). (i) BSA was added to
the in vitro transcription/translation system and resulted in
a 1.5-to-2-fold improvement; it may have acted as a ‘bulk’
protein and prevented the in vitro transcription/translation
system and/or the synthesized Fab fragments from
becoming trapped and denatured at the oil/water interface
of the micelles, (ii) The stirring time was reduced from 3
to 0.5min; this resulted in a 1.5-to-2-fold improvement.
Reducing the stirring time may have reduced the
physical strain on the in vitro transcription/translation
system, (iii) The surfactant was changed from Tween 20
to Tween 80, which resulted in a 2-to-2.5-fold improve-
ment. Since Tween 20 and Tween 80 have diﬀerent eﬀects
on protein stability (19), changing the surfactant to Tween
80 may have increased the stability of the in vitro tran-
scription/translation system and/or the synthesized
Fab fragments, although the actual mechanism was not
established. When all three changes were made, an
improvement in DNA enrichment eﬃciency of approxi-
mately 10-fold was observed (Figure 3).
Under the modiﬁed emulsion preparation conditions,
micelles with a diameter range of 2–6mm, with a sharp
peak at around 4mm, were produced. This distribution
is the same as that found in our previous study on
DNA-displayed peptides (library size:  10
9), and 1ml of
emulsion provides 10
9–10
10 compartments, each of which
is expected to contain a single gene on average (13). Under
the improved conditions, iterative rounds of aﬃnity selec-
tion were carried out for ﬂuorescein-immobilized beads
from a mixture of 10
5 anti-p53 to 1 anti-ﬂuorescein Fab
fragment gene. After three rounds of aﬃnity selection,
anti-ﬂuorescein gene was antigen-speciﬁcally enriched
 10
6-fold ( 90-fold per round) (Figure 4).
Aﬃnity selection of randomized Fab fragments
Finally, we applied the improved DNA display procedure
for selection from a randomized Fab fragment library.
Figure 2. Conﬁrmation of cell-free synthesis and function of
streptavidin-fused Fab fragments. The template DNA for anti-
ﬂuorescein or anti-p53 Fab fragments was in vitro transcribed/translated
and subjected to pull-down assay (see ‘Materials and Methods’ section)
with ﬂuorescein or p53 C-terminal peptide-immobilized beads, respec-
tively. The input fraction before binding (I), the output fraction after
binding with antigen-immobilized beads (O) and the output fraction
after binding with mock beads with biotin (M) were resolved by
12.5% SDS–PAGE and detected by western blotting. Anti-myc mAb
was used to detect the streptavidin-fused H-chain (upper) and anti-
FLAG mAb was used to detect the L-chain (lower). Samples including
b-mercaptoethanol (b-ME, +) showed higher mobility.
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seven amino-acid residues from the hydrophobic interface
of the CH1 domain and the CL domain (Figure 5) to
random hydrophobic amino acids encoded by the NTK
codon (Phe, Leu, Ile, Met or Val). Previous reports have
indicated that alteration of the hydrophobic core results
in a change of stability and activity of various proteins
(20–23). The DNA library was constructed on the base
of anti-ﬂuorescein and was in vitro transcribed/translated,
and then the antigen-binding activity and heat stability
were compared with those of the wild-type anti-
ﬂuorescein. There was a change in heat stability, and ran-
domization decreased antigen-binding activity above 58 C
(Figure 6B), though there was no signiﬁcant change at
room temperature (Figure 6A). This is possibly because
the structure of the hydrophobic core could be maintained
by various hydrophobic amino acids at room temperature,
but more stringent combinations of hydrophobic amino
acids were needed to maintain the structure at higher
temperatures. Thus, we applied heat treatment as a selec-
tion pressure for in vitro selection of the randomized
library of the constant region. There have been other
Figure 5. Randomized residues of the hydrophobic core of the constant region. Seven residues from the hydrophobic interface of the CH1 domain
and the CL domain was picked up by referring to the 3-D structure of an anti-thyroid peroxidase Fab fragment (PDB ID: 1VGE), which has the
same constant region as the one used in this study. The residues are heavy chain Leu124, Leu141, Ser179, Val181 and light chain Phe118, Val133,
Leu135 [numbering according to Kabat et al. (30)]. The left picture shows the whole constant region and the right picture is a close-up of the area
inside the dotted lines. The blue ribbon shows the heavy chain and the green ribbon shows the light chain.
Figure 4. Speciﬁc enrichment of the anti-ﬂuorescein Fab fragment gene
by aﬃnity selection. Three rounds of aﬃnity selection with ﬂuorescein-
immobilized beads or mock beads were carried out from a DNA
mixture of 10
5 anti-p53 to 1 anti-ﬂuorescein Fab fragment gene (see
‘Materials and Methods’ section). (A) The DNA after each round of
selection was quantiﬁed by real-time PCR and the amount of anti-
ﬂuorescein divided by that of anti-p53 was plotted. (B) The DNA
after each round of selection was ampliﬁed by PCR with primers
Univ-F and STAsd-R using KOD-plus DNA polymerase and
digested with BamHI to cleave only anti-ﬂuorescein Fab fragment
genes. The products were resolved by 1.5% agarose gel electrophoresis
and detected by EtBr staining.
Figure 3. Changes of enrichment eﬃciency for Fab fragment DNA
under various conditions for emulsion preparation. One round of
aﬃnity selection with ﬂuorescein-immobilized beads (see ‘Materials
and Methods’ section) was carried out from a DNA mixture of 10
anti-p53 to 1 anti-ﬂuorescein Fab fragment gene and the enrichment
eﬃciency of anti-ﬂuorescein DNA was compared with the original
conditions (white bar: containing no BSA in the in vitro transcrip-
tion/translation system, having a stirring time of 3min to prepare the
emulsion, and using Tween 20). The enrichment eﬃciency was
calculated by dividing the relative amount of positive control DNA
after selection by that before selection.
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tion pressure, although in those cases, mutations were
introduced in variable regions (24,25).
After three rounds of aﬃnity selection for ﬂuorescein-
immobilized beads with and without heat treatment
(10min at 63 C), 18 variants from each situation were
sequenced (Table 2). Three rounds were suggested to be
suﬃcient, because the library consists of 8 10
5 (=5
7)
mutants and the wild type, whose antigen-binding
activity is unchanged (Figure 6A), showed  10
6-fold
enrichment per three rounds (Figure 4). The heat-
denaturation curves for arbitrarily chosen variants
selected without heat treatment (Figure 7A) had a broad
distribution around the denaturation curve of the
randomized library (Figure 6B). By introducing heat treat-
ment as a selection pressure, we expected that unstable
variants would be eliminated and stable variants
selected. Consequently, arbitrarily chosen variants
selected with heat treatment had improved heat stability
compared to the initial randomized library, though the
stability did not greatly exceed that of wild-type anti-
ﬂuorescein (Figure 7B). The altered residues had nothing
particular in common, suggesting that a range of
sequences is acceptable to maintain the structure of the
hydrophobic core, in agreement with previous reports
(20–22).
The Kd values of some of the chosen variants, including
the wild type, were determined and they all had a similar
value of  2nM (Table 2). This ﬁnding that alteration of
the hydrophobic core in the constant region did not
greatly aﬀect the aﬃnity is reasonable, because (i) there
was no particular selection pressure on dissociation in this
study, e.g., the presence of competitor (5) or lowered con-
centration of antigen (8) during selection, (ii) the altered
constant region is apart from the antigen-binding variable
region (10), and (iii) mutations associated with aﬃnity
maturation are most likely to be found in the CDRs of
the variable region (5,8,25).
In conclusion, it was conﬁrmed that DNA display was
able to select Fab fragment candidates according to the
designed procedure. We also found that the hydrophobic
Table 2. Amino acid sequences of the selected Fab fragment variants
ID Altered amino-acid residues
Characteristics CH1 CL
124 141 179 181 118 133 135 Tm ( C) Kd (nM)
WT L L S V F V L 63.6 1.8
N-1 V I V V F V L 63.5 2.8
N - 2 VVI I LVL
N-3 F V V V M M V 61.2
N - 4 LM VLLVL
N-5 I V L V M F F 60.7 3.4
N-6 L M L V L F F 60.4
N-7 L V V M V L F
N - 8 M VLLFLV
N - 9 LI LM M LL
N-10 L L M V I F V
N-11 I V V V L L V
N-12 FLLLFI L
N-13 V L F L F V L 56.2 1.4
N-14 I M V M I V L
N-15 I L L F M V L
N-16 M F L I I V I
N-17 L M F V L M V
N-18 V L M M L L L
H-1 M L S V L L L 63.3 1.6
H-2 L L S V M L F
H-3 V L V M F L L 63.4 2.6
H-4 L L M M L L V
H - 5 FVLVLVL
H - 6 LLLVVVV63.3
H-7 L L I V V V F
H - 8 MI V V MMI
H-9 L V V V M V I
H-10 V F L I V F V
H-11 V V I I F V L
H-12 LLLVM VF63.5 3.2
H-13 L L I M L V L
H-14 I F F V F I V
H-15 V L V L F L L 63.2
H-16 V L L L L V V
H-17 V L V F F L V 63.5
H-18 LLLLLLV
WT, wild type; N-X, selected variants without heat treatment; H-X,
selected variants with heat treatment.
Figure 6. Binding activity and heat stability for the anti-ﬂuorescein
Fab fragment (wild type) and a mixture of the variants with
randomized constant region (library). (A) Antigen binding activity at
room temperature was measured by ELISA (see ‘Materials and
Methods’ section). The absorbance at 450nm (reference at 655nm) of
the wild type was used for normalization. (B) Heat denaturation curves
of the wild type (solid line) and the library (dotted line) were measured
by heat-denaturation ELISA (see ‘Materials and Methods’ section).
The absorbance at 450nm (reference at 655nm) of each sample
heated at 38.7 C was used for normalization.
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Possibly a diﬀerent strategy is needed in order to obtain a
more stable Fab fragment. Previous studies in which
hydrophobic cores were altered also did not obtain
enhanced variants (20–22), and introducing mutations at
locations other than hydrophobic cores may be more
eﬀective. For example, there has been one report in
which mouse IgG1 Fab fragments with increased stability
were obtained when a hydrophilic residue in the cavity of
the constant region was replaced with a hydrophobic
residue (9). A random mutagenesis strategy throughout
the whole constant region would be compatible with
in vitro selection of stable variants.
Comparison of DNA display with other antibody-display
methods
Various display methods have been used to select
recombinant antibody genes (Table 3), but most of them
have been designed to select scFvs (2,5,6,26–28). Display
methods selecting recombinant antibodies other than
scFvs are phage display and yeast-surface display, in
which Fab fragments are selected (7,8). However, due to
the use of living organisms, these methods suﬀer
limitations related to transfection eﬃciency and culture
time. Totally in vitro display methods can overcome
these limitations. The DNA display method described
here is the ﬁrst totally in vitro method to be applicable
to oligomeric Fab fragments.
A disadvantage of DNA display based on in vitro
compartmentalization (15) may be the relatively low con-
centration of DNA in a micelle. Since the average
diameter of a micelle is 4mm, the average volume would
be 0.03pl, in which the DNA would be present at 50pM
concentration. However, even if only a single copy of Fab
fragment was formed in a micelle, the subnanomolar con-
centration of DNA and protein is still high enough to
allow eﬃcient formation of DNA–protein conjugates
due to the subpicomolar aﬃnity of streptavidin and
biotinylated DNA. Also, since there are abundant
antigen molecules immobilized on beads for in vitro selec-
tion, the recovery eﬃciency is not greatly inﬂuenced by the
low concentration of DNA-displayed Fab fragments. In
this study, the recovery eﬃciency of DNA-displayed Fab
fragment, calculated from the input amount and recovered
amount of positive DNA in the model experiment
(Figure 3), turned out to be  1%. The low concentration
of DNA-displayed Fab fragments would inﬂuence the
eﬀective library size. To allow DNA display to handle
even larger library sizes, we are currently working on
increasing the concentration of DNA in a micelle by
combining emulsion PCR (29) with DNA display.
ACKNOWLEDGEMENTS
The authors thank Yuko Oishi for an initial contribution
to this project, and Yuko Kawahashi for providing
anti-p53 scFv gene and biotinylated p53 C-terminal
peptide.
Figure 7. Heat-denaturation curves of the variants selected from the
randomized Fab fragment library without (A) and with (B) heat treat-
ment as the selection pressure. Heat-denaturation ELISA was per-
formed as described in ‘Materials and Methods’ section. The
absorbance at 450nm (reference at 655nm) of each sample heated at
38.7 C was used for normalization. (A) The curves of N-1, N-3, N-5,
N-6 and N-13 (Table 2) are plotted in blue, red, yellow, green and
purple, respectively. (B) The curves of H-1, H-3, H-6, H-12, H-15
and H-17 (Table 2) are plotted in blue, red, yellow, green, purple
and orange, respectively. The dotted line and solid line in each panel
represent the Tm of the initial randomized library and the wild-type
anti-ﬂuorescein Fab fragment, respectively.
Table 3. Comparison of DNA display with other antibody-display methods
Display type Phage display Yeast display Ribosome display mRNA display CAD DNA display
Genotype Phagemid Plasmid mRNA mRNA DNA DNA
Phenotype scFv/Fab scFv/Fab scFv scFv scFv Fab
Refs. (7,26) (8,27) (2) (5,6) (28) This study
Use of organisms Yes Yes No No No No
Library size 10
7–10
9 10
6–10
7 10
11–10
12 10
11–10
12 10
11–10
12 10
9–10
10
Selection speed (per round) 3days 3–4days 0.5day 0.5–1day 0.5day 0.5day
CAD, covalent antibody display.
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